Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 68


A practical approach to the management of nocturia.

Oelke M, De Wachter S, Drake MJ, Giannantoni A, Kirby M, Orme S, Rees J, van Kerrebroeck P, Everaert K.

Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.13027. Epub 2017 Oct 5.


Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.

Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarría VV, Muñoz Venturelli P, Brunser A, Peng B, Cui L, Song L, Rogers K, Middleton S, Lim JY, Forshaw D, Lightbody CE, Woodward M, Pontes-Neto O, De Silva HA, Lin RT, Lee TH, Pandian JD, Mead GE, Robinson T, Watkins C; HeadPoST Investigators and Coordinators.

N Engl J Med. 2017 Jun 22;376(25):2437-2447. doi: 10.1056/NEJMoa1615715.


High-dose oral colecalciferol loading in obesity: impact of body mass index and its utility prior to bariatric surgery to treat vitamin D deficiency.

King RJ, Chandrajay D, Abbas A, Orme SM, Barth JH.

Clin Obes. 2017 Apr;7(2):92-97. doi: 10.1111/cob.12176. Epub 2017 Feb 1.


Understanding help-seeking in older people with urinary incontinence: an interview study.

Vethanayagam N, Orrell A, Dahlberg L, McKee KJ, Orme S, Parker SG, Gilhooly M.

Health Soc Care Community. 2017 May;25(3):1061-1069. doi: 10.1111/hsc.12406. Epub 2016 Nov 16.


Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland.

Radian S, Diekmann Y, Gabrovska P, Holland B, Bradley L, Wallace H, Stals K, Bussell AM, McGurren K, Cuesta M, Ryan AW, Herincs M, Hernández-Ramírez LC, Holland A, Samuels J, Aflorei ED, Barry S, Dénes J, Pernicova I, Stiles CE, Trivellin G, McCloskey R, Ajzensztejn M, Abid N, Akker SA, Mercado M, Cohen M, Thakker RV, Baldeweg S, Barkan A, Musat M, Levy M, Orme SM, Unterländer M, Burger J, Kumar AV, Ellard S, McPartlin J, McManus R, Linden GJ, Atkinson B, Balding DJ, Agha A, Thompson CJ, Hunter SJ, Thomas MG, Morrison PJ, Korbonits M.

Hum Mutat. 2017 Jan;38(1):78-85. doi: 10.1002/humu.23121. Epub 2016 Oct 4.


Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours.

Kyriakakis N, Lynch J, Orme SM, Gerrard G, Hatfield P, Loughrey C, Short SC, Murray RD.

Clin Endocrinol (Oxf). 2016 Mar;84(3):372-9. doi: 10.1111/cen.12969. Epub 2015 Nov 24.


Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.

Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M; International FIPA Consortium.

J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54.


Managing Urinary Incontinence in Patients with Dementia: Pharmacological Treatment Options and Considerations.

Orme S, Morris V, Gibson W, Wagg A.

Drugs Aging. 2015 Jul;32(7):559-67. doi: 10.1007/s40266-015-0281-x. Review.


Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance.

Eccles S, Pincus C, Higgins B, Woodhead M; Guideline Development Group.

BMJ. 2014 Dec 3;349:g6722. doi: 10.1136/bmj.g6722. No abstract available.


Lanreotide autogel in acromegaly - a decade on.

Kyriakakis N, Chau V, Lynch J, Orme SM, Murray RD.

Expert Opin Pharmacother. 2014 Dec;15(18):2681-92. doi: 10.1517/14656566.2014.970173. Epub 2014 Oct 11. Review.


Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.

Challis BG, Harris J, Sleigh A, Isaac I, Orme SM, Seevaratnam N, Dhatariya K, Simpson HL, Semple RK.

Clin Endocrinol (Oxf). 2014 Dec;81(6):855-61. doi: 10.1111/cen.12517. Epub 2014 Jul 2.


Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.

Williams F, Hunter S, Bradley L, Chahal HS, Storr HL, Akker SA, Kumar AV, Orme SM, Evanson J, Abid N, Morrison PJ, Korbonits M, Atkinson AB.

J Clin Endocrinol Metab. 2014 Apr;99(4):1122-31. doi: 10.1210/jc.2013-2868. Epub 2013 Jan 1.


Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists.

Howlett TA, Willis D, Walker G, Wass JA, Trainer PJ; UK Acromegaly Register Study Group (UKAR-3).

Clin Endocrinol (Oxf). 2013 Nov;79(5):689-99. doi: 10.1111/cen.12207. Epub 2013 Apr 24.


Management of lower urinary tract dysfunction in neurological disease: summary of NICE guidance.

Swain S, Hughes R, Perry M, Harrison S; Guideline Development Group.

BMJ. 2012 Aug 8;345:e5074. doi: 10.1136/bmj.e5074. No abstract available.


Fibrin clot structure and fibrinolysis in hypothyroid individuals: the effects of normalising thyroid hormone levels.

Stuijver DJ, Hooper JM, Orme SM, Van Zaane B, Squizzato A, Piantanida E, Hess K, Alzahrani S, Ajjan RA.

J Thromb Haemost. 2012 Aug;10(8):1708-10. doi: 10.1111/j.1538-7836.2012.04789.x. No abstract available.


Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.

Hooper JM, Stuijver DJ, Orme SM, van Zaane B, Hess K, Gerdes VE, Phoenix F, Rice P, Smith KA, Alzahrani SH, Standeven KF, Ajjan RA.

J Clin Endocrinol Metab. 2012 May;97(5):1463-73. doi: 10.1210/jc.2011-2894. Epub 2012 Feb 29.


The role and efficacy of denosumab in the treatment of osteoporosis: an update.

Charopoulos I, Orme S, Giannoudis PV.

Expert Opin Drug Saf. 2011 Mar;10(2):205-17. doi: 10.1517/14740338.2010.516249. Epub 2011 Jan 6. Review.


AIP mutation in pituitary adenomas in the 18th century and today.

Chahal HS, Stals K, Unterländer M, Balding DJ, Thomas MG, Kumar AV, Besser GM, Atkinson AB, Morrison PJ, Howlett TA, Levy MJ, Orme SM, Akker SA, Abel RL, Grossman AB, Burger J, Ellard S, Korbonits M.

N Engl J Med. 2011 Jan 6;364(1):43-50. doi: 10.1056/NEJMoa1008020.


Fracture risk associated with chronic use of bisphosphonates: evidence today.

Charopoulos I, Orme S, Giannoudis PV.

Expert Opin Drug Saf. 2011 Jan;10(1):67-76. doi: 10.1517/14740338.2010.517192. Epub 2010 Dec 2. Review.


Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide.

Blumsohn A, Marin F, Nickelsen T, Brixen K, Sigurdsson G, González de la Vera J, Boonen S, Liu-Léage S, Barker C, Eastell R; EUROFORS Study Group.

Osteoporos Int. 2011 Jun;22(6):1935-46. doi: 10.1007/s00198-010-1379-y. Epub 2010 Oct 12.

Supplemental Content

Loading ...
Support Center